July 10, 2017 Participation at the Annual Meeting on Continuous Biomanufacturing in Oxford, UK
From June 26 to 28 2017, the World Biopharm Forum staged the Annual Meeting on Continuous Biomanufacturing at the Lady Margaret Hall in the University of Oxford, UK. Scientists, technologists, engineers and others from across the world discussed the technical need and operational strategy for implementing continuous manufacturing in the biopharma industry.
Dr. Stefan Wieschalka, Senior Scientist Process Science at Rentschler, held a talk on scale-up and scale-down options for single-use technologies. In recent years, single-use equipment emerged as a successful approach in fed-batch and continuous biomanufacturing. It is therefore no surprise that single-use equipment is increasingly used in both, laboratory as well as production scale. On that basis, single-use systems broaden the toolbox for efficient development and cGMP manufacturing up to 2,000 L scale.
A case study on a high-throughput screening approach for process optimization with the miniaturized single-use bioreactor system ambr® 250 system showed the significant advantages of such system. It promises good control and high capacity with a short turnaround as well as flexibility and scalability.
Rentschler Biopharma SE
Dr. Cora Kaiser
Senior Director Corporate Communication